Skip to main content

Nephrology Publications

Below are recent PubMed publications by faculty members in the Division of Nephrology in the Department of Pediatrics at Northwestern University Feinberg School of Medicine.
  1. Engen RM, Sgambat K, Verghese PS, Jain A, Smith J, Twombley K, Amaral S, Zahr R, Bock M, Richardson K  et al.  Body mass index in pediatric kidney transplant selection criteria.  Pediatr Nephrol  2024 Nov;39(11):3333-3338. doi:10.1007/s00467-024-06453-y
  2. Langman CB, Delos Santos RB, Ghossein C, Atherton AM, Levtchenko EN, Servais A  Fertility Management in Cystinosis: A Clinical Perspective.  Kidney Int Rep  2024 Feb;9(2):214-224. doi:10.1016/j.ekir.2023.10.030
  3. Langman CB, Assimos D, Blank M, Calle J, Grauer A, Kausz A, Milliner D, Nazzal L, Smith K, Tasian G  et al.  End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.  Clin J Am Soc Nephrol  2023 Dec 01;18(12):1637-1644. doi:10.2215/CJN.0000000000000234
  4. Onder AM, Ansari MAY, Deng F, Grinsell MM, Patterson L, Jetton J, Fathallah-Shaykh S, Ranch D, Aviles D, Copelovitch L  et al.  Persistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium Study.  J Clin Med  2023 Jun 25;12(13). pii:4251
  5. Langman CB  Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis").  Orphanet J Rare Dis  2023 Jun 23;18(1):162. pii:162
  6. Corano Scheri K, Liang X, Dalal V, Le Poole IC, Varga J, Hayashida T  SARA suppresses myofibroblast precursor transdifferentiation in fibrogenesis in a mouse model of scleroderma.  JCI Insight  2022 Nov 08;7(21). pii:e160977
  7. Finer G, Maezawa Y, Ide S, Onay T, Souma T, Scott R, Liang X, Zhao X, Gadhvi G, Winter DR  et al.  Stromal Transcription Factor 21 Regulates Development of the Renal Stroma via Interaction with Wnt/β-Catenin Signaling.  Kidney360  2022 Jul 28;3(7):1228-1241. doi:10.34067/KID.0005572021
  8. Wu E, Lee JY, Gelarden I, Engen RM  Nondestructive versus advanced post-transplant lymphoproliferative disorder in a single-center pediatric kidney transplant population.  Pediatr Transplant  2022 Jun;26(4):e14238. doi:10.1111/petr.14238
  9. Engen RM, Weng PL, Shih W, Patel HP, Richardson K, Dowdrick SL, Ashoor IF, Misurac J, Traum AZ, Semanik MG  et al.  Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: A Pediatric Nephrology Research Consortium study.  Pediatr Transplant  2022 May;26(3):e14202. doi:10.1111/petr.14202
  10. Hoppe B, Koch A, Cochat P, Garrelfs SF, Baum MA, Groothoff JW, Lipkin G, Coenen M, Schalk G, Amrite A  et al.  Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria.  Kidney Int  2022 Mar;101(3):626-634. doi:10.1016/j.kint.2021.08.015
  11. Vaisbich MH, Caires Ferreira J, Price H, Young KD, Sile S, Checani G, Langman CB  Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosis.  JIMD Rep  2022 Jan;63(1):66-79. doi:10.1002/jmd2.12260

Follow Pediatrics on